The refillable eye implants continuously deliver a customised formulation of a drug over a period of several months. Read more at straitstimes.com. Read more at straitstimes.com.

Ozempic and Wegovy, used for diabetes and weight loss, are now linked to a rare eye condition called NAION, or "eye stroke." The European Medicines Agency reports it affects roughly 1 in 10,000 ...

Nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss, is a “very rare” side effect of treatment with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, ...

EMA says Ozempic, Wegovy may cause rare eye condition Author Sam Boughedda Stock Markets Published 06/06/2025, 06:56 AM ...

European health officials are warning that the popular weight-loss drugs Ozempic and Wegovy can cause a potentially dangerous eye condition as a side effect. The European Medicines Agency’s safety ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision ...

It was also an opportunity to create awareness of the condition Amblyopia, commonly known as 'lazy eye', and inform parents about the importance of patch wearing.

Researchers found that after one year, GLP-1 users were more than twice as likely to develop neovascular age-related macular degeneration than those who were not taking the drugs. Age-related ...

Ozempic, Wegovy linked to rare cases of eye disorder, EMA says By Staff Reuters Posted June 6, 2025 8:21 am 1 min read ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.

Investing.com -- The European Medicines Agency’s (EMA) safety committee, PRAC, said Friday that it has concluded that Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition ...

Date 2025-06-05 03:15:01 (MENAFN - Pressat) A charity supporting people living with a complex eye condition has won a top prize at the UK Charity Governance Awards 2025.